<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:ACON="http://aclarion.com/20241226">
<head>
     <title>Aclarion, Inc. S-1</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_021_US%2DGAAP%2D2024%2D(with%2DECD) -->
<!-- Field: Set; Name: xdx; ID: xdx_031_ACON_aclarion.com_20241226 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20241226_20241226 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DAmendmentFlag_true -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DAmendmentDescription_Exhibits only filing -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0001635077 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-12-26" id="Fact000003" name="dei:AmendmentFlag">true</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-12-26" id="Fact000004" name="dei:AmendmentDescription">Exhibits only filing</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-12-26" id="Fact000005" name="dei:EntityCentralIndexKey">0001635077</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="acon-20241226.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-12-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001635077</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-26</xbrli:startDate>
        <xbrli:endDate>2024-12-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>As filed with the Securities and Exchange Commission
on December 26, 2024</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><b>Registration No.
333-283724</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>SECURITIES AND EXCHANGE
COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>AMENDMENT NO. 1</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>TO</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>FORM </b> <span id="xdx_908_edei--DocumentType_c20241226__20241226_zg0Yly9s8eXh"><b><ix:nonNumeric contextRef="AsOf2024-12-26" id="Fact000011" name="dei:DocumentType">S-1/A</ix:nonNumeric></b><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>REGISTRATION STATEMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b><i>UNDER</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b><i>THE SECURITIES ACT
OF 1933</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><span style="font-size: 12pt"><b><span id="xdx_909_edei--EntityRegistrantName_c20241226__20241226_zrDRsupU13Rf"><ix:nonNumeric contextRef="AsOf2024-12-26" id="Fact000012" name="dei:EntityRegistrantName">Aclarion,
Inc.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">(Exact name of registrant
as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 32%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityIncorporationStateCountryCode_c20241226__20241226_zwWLYVDsTFAe"><ix:nonNumeric contextRef="AsOf2024-12-26" format="ixt-sec:stateprovnameen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 1%; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; width: 34%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8071</b></span></td>
    <td style="vertical-align: bottom; width: 1%; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; width: 32%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--EntityTaxIdentificationNumber_c20241226__20241226_zLi06rzbq0Lc"><ix:nonNumeric contextRef="AsOf2024-12-26" id="Fact000014" name="dei:EntityTaxIdentificationNumber">47-3324725</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(State or other jurisdiction of</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">incorporation or organization)</p></td>
    <td style="vertical-align: bottom; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Primary Standard Industrial</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Classification Code Number)</p></td>
    <td style="vertical-align: bottom; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(I.R.S. Employer</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Identification Number)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b><span id="xdx_905_edei--EntityAddressAddressLine1_c20241226__20241226_zMQmN5pPBEV"><ix:nonNumeric contextRef="AsOf2024-12-26" id="Fact000015" name="dei:EntityAddressAddressLine1">8181 Arista Place</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressAddressLine2_c20241226__20241226_zpY62ERy2LS"><ix:nonNumeric contextRef="AsOf2024-12-26" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite
100</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b><span id="xdx_90A_edei--EntityAddressCityOrTown_c20241226__20241226_z9Auw8ScQHBb"><ix:nonNumeric contextRef="AsOf2024-12-26" id="Fact000017" name="dei:EntityAddressCityOrTown">Broomfield</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressStateOrProvince_c20241226__20241226_zXUMhV32Stbb"><ix:nonNumeric contextRef="AsOf2024-12-26" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Colorado</ix:nonNumeric></span> <span id="xdx_90F_edei--EntityAddressPostalZipCode_c20241226__20241226_zPbeQtHopGd1"><ix:nonNumeric contextRef="AsOf2024-12-26" id="Fact000019" name="dei:EntityAddressPostalZipCode">80021</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>(<span id="xdx_90A_edei--CityAreaCode_c20241226__20241226_zR0Vht2vCgEb"><ix:nonNumeric contextRef="AsOf2024-12-26" id="Fact000020" name="dei:CityAreaCode">833</ix:nonNumeric></span>) <span id="xdx_902_edei--LocalPhoneNumber_c20241226__20241226_zBEfagMjY7L"><ix:nonNumeric contextRef="AsOf2024-12-26" id="Fact000021" name="dei:LocalPhoneNumber">275-2266</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">(Address, including zip code,
and telephone number, including area code, of registrant&#8217;s principal executive offices)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>John Lorbiecki</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>Chief Financial Officer</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>Aclarion, Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>8181 Arista Place, Suite
100</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>Broomfield, Colorado 80021</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>(833) 275-2266</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">(Name, address, including
zip code, and telephone number, including area code, of agent for service)</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b><i>Copies to:</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Ralph V. De Martino, Esq. </span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 40%"><span style="font-size: 10pt">James H. Carroll, Esq.</span></td>
    <td style="width: 20%">&#160;</td>
    <td style="width: 40%"><span style="font-size: 10pt">Marc E. Rivera, Esq. </span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">Carroll Legal LLC</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">ArentFox Schiff LLP </span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">1449 Wynkoop Street, Suite 507</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">1717 K Street NW </span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">Denver, CO&#160;&#160;80202</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Washington, D.C. 20006 </span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(303) 888-4859</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">(202) 724-6848</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Approximate date of commencement of proposed sale to the public:
As soon as practicable after the effective date of this Registration Statement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">If any of the securities
being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act, check
the following box.&#160;&#160;<span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">If this Form is filed
to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering.&#160;&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">If this Form is a post-effective
amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering.&#160;&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">If this Form is a post-effective
amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Indicate by check mark
whether the registrant is a large accelerated filer, an accelerated filer, a&#160;non-accelerated&#160;filer, a smaller reporting company
or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller
reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 20%"><span style="font-size: 10pt">Large&#160;accelerated&#160;filer</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 42%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 20%"><span style="font-size: 10pt">Accelerated&#160;filer</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt"><span id="xdx_905_edei--EntityFilerCategory_c20241226__20241226_zygKlAZkpGpl"><ix:nonNumeric contextRef="AsOf2024-12-26" format="ixt-sec:entityfilercategoryen" id="Fact000022" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Smaller&#160;reporting&#160;company</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--EntitySmallBusiness_c20241226__20241226_zJEL7VDNmQk9"><ix:nonNumeric contextRef="AsOf2024-12-26" format="ixt:booleantrue" id="Fact000023" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="white-space: nowrap"><span style="font-size: 10pt">Emerging&#160;growth&#160;company</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EntityEmergingGrowthCompany_c20241226__20241226_zQjPAdgpw2Hk"><ix:nonNumeric contextRef="AsOf2024-12-26" format="ixt:booleantrue" id="Fact000024" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 26.6pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.&#160;&#160;<span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_edei--EntityExTransitionPeriod_c20241226__20241226_zsso39n8aDU3"><ix:nonNumeric contextRef="AsOf2024-12-26" format="ixt:booleanfalse" id="Fact000025" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>The Registrant hereby
amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file
a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section
8(a) of the Securities Act of 1933, as amended, or until this Registration Statement shall become effective on such date as the Securities
and Exchange Commission, acting pursuant to said Section&#160;8(a), may determine.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>EXPLANATORY NOTE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Aclarion, Inc. is filing this Amendment
No. 1 (the &#8220;Amendment&#8221;) to its Registration Statement on Form S-1 (File No. 333-283724) as an exhibit only filing to file
Exhibit 1.1, Exhibit 4.8, Exhibit 4.9. Exhibit 4.10, Exhibit 4.11, Exhibit 4.12, Exhibit 4.13, Exhibit 5.1 and Exhibit 23.3. Accordingly,
this Amendment consists only of the facing page, this explanatory note, Part II of the Registration Statement, the signature pages to
the Registration Statement and the filed exhibits. The prospectus is unchanged and has been omitted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<!-- Field: Page; Sequence: 203; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>PART II</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>INFORMATION NOT REQUIRED
IN PROSPECTUS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 9%; font-size: 10pt"><span style="font-size: 10pt"><b>Item&#160;13.</b></span></td>
    <td style="font-size: 10pt"><span style="font-size: 10pt"><b>Other Expenses of Issuance and Distribution.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The following table sets
forth the costs and expenses, other than the underwriting discounts and commissions, payable in connection with the sale of common stock
being registered. All amounts shown are estimates, except the Securities and Exchange Commission registration fee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Securities and Exchange Commission registration fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,822.65</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Financial Industry Regulatory Authority filing fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">[***]</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Legal fees and expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">[***]</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accountants&#8217; fees and expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">[***]</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Printing expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">[***]</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Transfer agent and registrar fees and expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">[***]</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt">Miscellaneous</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">[***]</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 83%; padding-bottom: 2.5pt">Total</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right">250,000</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 9%"><span style="font-size: 10pt"><b>Item&#160;14.</b></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b>Indemnification of Directors and Officers.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We are incorporated under
the laws of the state of Delaware. Section 145 of the Delaware General Corporation Law provides that a Delaware corporation may indemnify
any persons who are, or are threatened to be made, parties to any threatened, pending or completed action, suit or proceeding, whether
civil, criminal, administrative or investigative (other than an action by or in the right of such corporation), by reason of the fact
that such person was an officer, director, employee or agent of such corporation, or is or was serving at the request of such person as
an officer, director, employee or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys&#8217;
fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action,
suit or proceeding, provided that such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed
to the corporation&#8217;s best interests and, with respect to any criminal action or proceeding, had no reasonable cause to believe that
his or her conduct was illegal. A Delaware corporation may indemnify any persons who are, or are threatened to be made, a party to any
threatened, pending or completed action or suit by or in the right of the corporation by reason of the fact that such person was a director,
officer, employee or agent of such corporation, or is or was serving at the request of such corporation as a director, officer, employee
or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys&#8217; fees) actually and reasonably
incurred by such person in connection with the defense or settlement of such action or suit provided such person acted in good faith and
in a manner he or she reasonably believed to be in or not opposed to the corporation&#8217;s best interests except that no indemnification
is permitted without judicial approval if the officer or director is adjudged to be liable to the corporation. Where an officer or director
is successful on the merits or otherwise in the defense of any action referred to above, the corporation must indemnify him or her against
the expenses that such officer or director has actually and reasonably incurred. Our charter and bylaws provide for the indemnification
of our directors and officers to the fullest extent permitted under the Delaware General Corporation Law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Section 102(b)(7) of
the Delaware General Corporation Law permits a corporation to provide in its certificate of incorporation that a director of the corporation
shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duties as a director,
except for liability for:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="width: 24px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 24px; text-align: justify"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">any breach of the director&#8217;s duty of loyalty to the corporation or its stockholders;</span></td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;</span></td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">any act related to unlawful stock repurchases, redemptions or other distributions or payment of dividends; or</span></td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">any transaction from which the director derived an improper personal benefit.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 204; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">These limitations of
liability do not affect the availability of equitable remedies such as injunctive relief or rescission. Our charter also authorizes us
to indemnify our officers, directors and other agents to the fullest extent permitted under Delaware law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As permitted by Section
145 of the Delaware General Corporation Law, our bylaws provide that:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="width: 24px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 24px; text-align: justify"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">we may indemnify our directors, officers and employees to the fullest extent permitted by the Delaware General Corporation Law, subject to limited exceptions;</span></td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">we may advance expenses to our directors, officers and employees in connection with a legal proceeding to the fullest extent permitted by the Delaware General Corporation Law, subject to limited exceptions; and</span></td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">the rights provided in our bylaws are not exclusive.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Section 174 of the Delaware
General Corporation Law provides, among other things, that a director who willfully or negligently approves of an unlawful payment of
dividends or an unlawful stock purchase or redemption may be held liable for such actions. A director who was either absent when the unlawful
actions were approved, or dissented at the time, may avoid liability by causing his or her dissent to such actions to be entered in the
books containing minutes of the meetings of the board of directors at the time such action occurred or immediately after such absent director
receives notice of the unlawful acts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As permitted by the Delaware
General Corporation Law, we have entered and expect to continue to enter into agreements to indemnify our directors, executive officers
and other employees as determined by our board of directors. Under the terms of our indemnification agreements, we are required to indemnify
each of our directors and officers, to the fullest extent permitted by the laws of the state of Delaware, if the basis of the indemnitee&#8217;s
involvement was by reason of the fact that the indemnitee is or was a director, or officer, of the company or any of its subsidiaries
or was serving at the company&#8217;s request in an official capacity for another entity. We must indemnify our officers and directors
against (1) attorneys&#8217; fees and (2) all other costs of any type or nature whatsoever, including any and all expenses and obligations
paid or incurred in connection with investigating, defending, being a witness in, participating in (including on appeal) or preparing
to defend, be a witness or participate in any completed, actual, pending or threatened action, suit, claim or proceeding, whether civil,
criminal, administrative or investigative, or establishing or enforcing a right to indemnification under the indemnification agreement.
The indemnification agreements also set forth certain procedures that will apply in the event of a claim for indemnification thereunder.
These indemnification provisions and the indemnification agreements may be sufficiently broad to permit indemnification of our officers
and directors for liabilities, including reimbursement of expenses incurred, arising under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In addition, we have
purchased a policy of directors&#8217; and officers&#8217; liability insurance that insures our directors and officers against the cost
of defense, settlement or payment of a judgment in some circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The form of Underwriting
Agreement, filed as Exhibit 1.1 hereto, provides for indemnification by the underwriter of us and our officers who sign this Registration
Statement and directors for specified liabilities, including matters arising under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 9%; text-align: justify"><span style="font-size: 10pt"><b>Item 15.</b></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b>Recent Sales of Unregistered Securities.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Note: Data in this Item
15 has not been adjusted for our recent reverse stock split in January 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">During the three-year
period preceding the date of filing of this registration statement, we have issued securities in the transactions described below without
registration under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In February 2020, the
Company issued to NuVasive a $2 million &#8220;SAFE&#8221; (Simple Agreement for Future Equity). In December 2021, the SAFE was converted
into shares of Series B-2 Preferred Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In February 2020 and
continuing through June 2021, the Company initiated a financing in the form of 6% Convertible Promissory Notes due June 30, 2021. This
financing raised $2,130,010 during 2020 and $814,000 during the first six months of 2021. In December 2021, all notes were converted into
shares of Series B-3 Preferred Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In connection with the
above-referenced note financing, the Company also issued certain common stock warrants. Such warrants were exercised immediately prior
to the Company&#8217;s April 2022 IPO, resulting in the issuance of 76,156 shares (post-reverse stock split) of common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 205 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In June 2021, the Company
issued $2.0 million of Promissory Notes that mature at the earlier of the consummation of a Qualified Financing or May 31, 2022. The notes
incorporated the following major attributes; interest on the Notes accrues at 33%, and the accrued interest would automatically convert
into the securities offered in a Qualified Financing, at a per security price equal to the offering price of the Qualified Financing multiplied
by 0.30 (70% discount).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">From January 1, 2019
through the date of the Company&#8217;s April 2022 IPO, we granted to our consultants, employees, officers and directors options to purchase
an aggregate of 16,073,154 shares (pre-reverse stock split) of Common Stock at per share exercise prices ranging from $0.18 to $0.26 (pre-reverse
stock split) under our 2015 Stock Plan. Included in those totals were grants made during 2021 of options to purchase an aggregate of 14,234,688
shares (pre-reverse stock split) of Common Stock at a per share exercise price of $0.26 (pre-reverse stock split).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">From January 1, 2019
through the date of the Company&#8217;s April 2022 IPO, we granted to our consultants, employees, officers and directors options to purchase
an aggregate of 16,073,154 shares (pre-reverse stock split) of Common Stock at per share exercise prices ranging from $0.18 to $0.26 (pre-reverse
stock split) under our 2015 Stock Plan. Included in those totals were grants made during 2021 of options to purchase an aggregate of 14,234,688
shares (pre-reverse stock split) of Common Stock at a per share exercise price of $0.26 (pre-reverse stock split).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">From January 1, 2019
through the date of the Company&#8217;s April 2022 IPO, we issued an aggregate of 10,000 shares of Common Stock pursuant to the exercise
of options by our consultants, employees, officers and directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In connection with our
April 2022 IPO:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">certain outstanding common stock warrants were exercised on a net share basis for 60,408 common shares&#894;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">24,495,004 (pre-split) outstanding shares of our preferred stock were converted into 3,279,117 post-split shares of common stock&#894;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">all accrued dividends on our outstanding Series B, B-1, B-2 and B-3 preferred stock were converted to 984,429 post-split common shares&#894;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">all accrued interest on the Company's outstanding secured promissory notes was converted into (i) 426,768 post-split common shares and (ii) 426,768 post-split common stock warrants, with beneficial conversion rates charged to interest expense upon conversion; and</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Symbol; font-size: 10pt">&#183;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">we issued to the representative of the underwriters a common stock warrant for 173,200 shares with an exercise price of $5.44 per share. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In November 2022, we
issued 40,000 unregistered and restricted shares to a vendor as partial payment for services rendered by such vendor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In May and September
2023, we issued $2.3 million of unsecured non-convertible promissory notes. In connection with this note issuance, the Company issued
(x) 339,360 shares of common stock as a commitment fee, (y) 1,232,156 common stock warrants with a five-year term and an initial exercise
price of $0.6262 per share, and (z) 100,973 prefunded common stock warrants to a broker dealer firm as a commission.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2023, we entered into an equity line
common stock purchase agreement (the &#8220;Purchase Agreement&#8221;) with White Lion Capital LLC. Pursuant to the Purchase Agreement,
the Company has the right, but not the obligation, to require White Lion to purchase, from time to time, up to $10,000,000 in aggregate
gross purchase price of newly issued shares of the Company&#8217;s common stock, subject to certain limitations and conditions set forth
in the Purchase Agreement. This includes 187,500 shares of common stock we issued to White Lion as commitment shares. In October 2023,
we sold 375,000 shares of common stock to White Lion pursuant to the Purchase Agreement. Through September 30, 2024, the Company has
issued 1,800,000 shares to White Lion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 206 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In November 2023, we
issued $294,117.65 of unsecured non-convertible promissory notes. In connection with this note issuance, the Company issued (x) 148,978
shares of common stock as a commitment fee, (y) 744,890 common stock warrants with a five-year term and an initial exercise price of $0.2865
per share, and (z) 25,210 prefunded common stock warrants to a broker dealer firm as a commission.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">From January 22 through
January 29, 2024, we issued 644,142 shares of common stock in connection with a series of exchange agreements with the accredited investors
to exchange principal and accrued interest on the certain outstanding non-convertible note for shares of common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We issued 930 shares of newly issued Series B
convertible preferred stock on August 14, 2024. The Series B Preferred Stock is convertible into common stock at an initial conversion
price of $0.234 per share of common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We issued 1,000 shares of newly issued Series
C convertible preferred stock on September 30, 2024. The Series C Preferred Stock is convertible into common stock at an initial conversion
price of $0.1759 per share of common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 27, 2024, the Company and White Lion
entered into an amendment to the Equity Line Purchase Agreement that (subject to stockholder approval), among other things, extended the
expiration date of the Equity Line Purchase Agreement from December 31, 2024 to December 31, 2025. In consideration for the commitments
of White Lion under this amendment, the Company issued to White Lion 560,915 shares of Common Stock as commitment shares, having a value
of $100,000 based upon the Nasdaq minimum price closing sale price of the Common Stock determined as of November 27, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">These sales and issuances
were made in reliance upon Section 3(a)(9) or Section 4(a)(2) of the Securities Act of 1933, as amended, and Regulation D, Rule 506 (d),
and did not involve any placement agents, commissions, or any public offering. The persons and entities who received such securities have
represented their intention to acquire these securities for investment only and not with a view to or for sale in connection with any
distribution thereof, and appropriate legends are be affixed to all share certificates issued. All recipients have adequate access through
their relationship with us to information about us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<!-- Field: Page; Sequence: 207 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 9%"><span style="font-size: 10pt"><b>Item&#160;16.</b></span></td>
    <td><span style="font-size: 10pt"><b>Exhibits and Financial Statement Schedules.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><b>(a)
Exhibits</b>. The following exhibits are filed as part of this Registration Statement:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 5%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Exhibit</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Number</b></p></td>
    <td style="width: 4%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 58%; text-align: center"><span style="font-size: 10pt"><b>Description of Document</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 6%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Incorporated by </b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>reference from Form</b></p></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Filing</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date</b></p></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 5%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exhibit</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Number</b></p></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 5%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Filed </b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Herewith</b></p></td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt;">1.1</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="aclarion_ex0101.htm"><span style="font-size: 10pt">Form
    of Underwriting Agreement</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt;">X</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">1.2</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316822002974/aclarion_ex0101.htm"><span style="font-size: 10pt">IPO Underwriting Agreement dated April 21, 2022</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">04-27-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">1.1</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">1.3</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316824001147/aclarion_ex0101.htm"><span style="font-size: 10pt">Form of February 2024 Placement Agent Agreement</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">02-23-2024</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">1.1</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">3.1</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822002974/aclarion_ex0301.htm"><span style="font-size: 10pt">Amended and Restated Certificate of Incorporation of the Company</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">04-27-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">3.1</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">3.2</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316824000066/acon_ex0301.htm"><span style="font-size: 10pt">Certificate of Amendment dated January 3, 2024 to the Amended and Restated Certificate of Incorporation</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">01-04-2024</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">3.1</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">3.3</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822002974/aclarion_ex0302.htm"><span style="font-size: 10pt">Bylaws of the Company</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">04-27-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">3.2</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">3.4</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316823001027/aclarion_ex0301.htm"><span style="font-size: 10pt">Certificate of Designation of Series A Preferred Stock</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">02-17-2023</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">3.1</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top">3.5</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316824004321/acon_ex0301.htm">Amendment to Bylaws dated June 12, 2024</a></td>
    <td>&#160;</td>
    <td style="vertical-align: top">8-K</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">6-18-2024</td>
    <td>&#160;</td>
    <td style="vertical-align: top">3.1</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top">3.6</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><p style="margin: 0pt 0"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316824005844/acon_ex0301.htm">Series B Convertible Preferred Stock Certificate of Designations dated August 14, 2024</a></p></td>
    <td>&#160;</td>
    <td style="vertical-align: top">8-K</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">08-16-2024</td>
    <td>&#160;</td>
    <td style="vertical-align: top">3.1</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top">3.7</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316824006791/acon_ex0301.htm">Series C Convertible Preferred Stock Certificate of Designations dated September 30, 2024</a></td>
    <td>&#160;</td>
    <td style="vertical-align: top">8-K</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">10-01-2024</td>
    <td>&#160;</td>
    <td style="vertical-align: top">3.1</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">4.1</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000165495422007977/aclarion_ex41.htm"><span style="font-size: 10pt">Form of Common Stock Certificate</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10-Q</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">06-06-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">4.1</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">4.2</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822002974/aclarion_ex0401.htm"><span style="font-size: 10pt">Form of IPO Warrant</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">04-27-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">4.1</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">4.3</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822002974/aclarion_ex0402.htm"><span style="font-size: 10pt">Form of IPO Representative&#8217;s Common Stock Purchase Warrant</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">04-27-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">4.2</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">4.4</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000165495422007977/aclarion_ex44.htm"><span style="font-size: 10pt">Description of Securities</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10-Q</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">06-06-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">4.4</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">4.5</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316824000730/aclarion_ex0405.htm"><span style="font-size: 10pt">February 2024 Form of Common Warrant</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">02-06-2024</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">4.5</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">4.6</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316824000730/aclarion_ex0406.htm"><span style="font-size: 10pt">February 2024 Form of Pre-Funded Warrant</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">02-06-2024</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">4.6</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">4.7</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316824001147/aclarion_ex0407.htm"><span style="font-size: 10pt">February 2024 Form of Warrant Agency Agreement</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">02-23-2024</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">4.7</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt;">4.8</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="aclarion_ex0408.htm"><span style="font-size: 10pt">Form
    of Series A Common Warrant</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt;">X</span></td></tr>
  <tr>
    <td style="vertical-align: top">4.9</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="aclarion_ex0409.htm">Form of Series
    B Common Warrant</a></td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">X</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt;">4.10</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="aclarion_ex0410.htm"><span style="font-size: 10pt">Form
    of Pre-Funded Warrant</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt;">X</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt;">4.11</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="aclarion_ex0411.htm"><span style="font-size: 10pt">Form
    of Securities Purchase Agreement</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt;">X</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt;">4.12</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="aclarion_ex0412.htm"><span style="font-size: 10pt">Form
    of Warrant Agency Agreement</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt;">X</span></td></tr>
  <tr>
    <td style="vertical-align: top">4.13</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="aclarion_ex0413.htm">Form of Lock-Up
    Agreement</a></td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">X</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt;">5.1</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt;"><a href="aclarion_ex0501.htm">Opinion of Carroll Legal LLC</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt;">X</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.1</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">#</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822001851/aclarion_ex1001.htm"><span style="font-size: 10pt">Employment Agreement of Jeff Thramann</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">03-23-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.2</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">#</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822001851/aclarion_ex1002.htm"><span style="font-size: 10pt">Employment Agreement of Brent Ness</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">03-23-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.2</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.3</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">#</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822001851/aclarion_ex1003.htm"><span style="font-size: 10pt">Employment Agreement of John Lorbiecki</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">03-23-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.3</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.4</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">#</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822000097/aclarion_ex1004.htm"><span style="font-size: 10pt">Form of Aclarion, Inc. 2022 Equity Incentive Plan</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">01-06-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.4</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.5</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822001434/aclarion_ex1005.htm"><span style="font-size: 10pt">Senior Secured Bridge Note</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">03-04-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.5</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.6</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822000097/aclarion_ex1006.htm"><span style="font-size: 10pt">License Agreement with UCSF the Regents of the University of California</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">01-06-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.6</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.7</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822001434/aclarion_ex1007.htm"><span style="font-size: 10pt">Amendment to UC License Agreement</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">03-04-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.7</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.8</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">**</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822001851/aclarion_ex1008.htm"><span style="font-size: 10pt">NuVasive Amended and Restated Commission Agreement dated February 28, 2020</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">03-23-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.8</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.9</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822001851/aclarion_ex1009.htm"><span style="font-size: 10pt">Amended and Restated Investor Rights Agreement dated July 27, 2017</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">03-23-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.9</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.10</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822001851/aclarion_ex1010.htm"><span style="font-size: 10pt">First Amendment to Amended and Restated Investor Rights Agreement dated February 20, 2020</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">03-23-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.10</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.11</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822001851/aclarion_ex1011.htm"><span style="font-size: 10pt">NuVasive SAFE (Simple Agreement for Future Equity) dated February 28, 2020</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">03-23-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.11</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.12</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">**</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822001851/aclarion_ex1012.htm"><span style="font-size: 10pt">Right of First Offer Agreement</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">03-23-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.12</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.13</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822001851/aclarion_ex1013.htm"><span style="font-size: 10pt">First Amendment to Right of First Offer Agreement</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">03-23-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.13</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.14</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822001851/aclarion_ex1014.htm"><span style="font-size: 10pt">Second Amendment to Right of First Offer Agreement</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">03-23-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.14</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.15</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822001851/aclarion_ex1016.htm"><span style="font-size: 10pt">Convertible Note and Warrant Purchase Agreement</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">03-23-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.16</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.16</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822002974/aclarion_ex1001.htm"><span style="font-size: 10pt">Warrant Agent Agreement dated April 21, 2022</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">04-27-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 208 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom"><span style="font-size: 10pt"><b>Exhibit Number</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><b>Description of Document</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><b>Incorporated by reference from Form</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><b>Filing Date</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><b>Exhibit Number</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><b>Filed Herewith</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; width: 5%"><span style="font-size: 10pt">10.17</span></td>
    <td style="width: 4%">&#160;</td>
    <td style="vertical-align: top; width: 58%; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822000097/aclarion_ex1017.htm"><span style="font-size: 10pt">Siemens Strategic Collaboration Agreement</span></a></td>
    <td style="width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 6%"><span style="font-size: 10pt">S-1</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 10%; text-align: center"><span style="font-size: 10pt">01-06-2022</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 5%"><span style="font-size: 10pt">10.17</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 5%; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.18</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">#</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822000097/aclarion_ex1020.htm"><span style="font-size: 10pt">Aclarion, Inc. 2022 Equity Incentive Plan &#8211; Form of Option Grant Notice and Stock Option Agreement</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">01-06-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.20</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.19</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">#</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822000097/aclarion_ex1021.htm"><span style="font-size: 10pt">Aclarion, Inc. 2022 Equity Incentive Plan &#8211; Form of RSU Grant Notice and RSU Agreement</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">01-06-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.21</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.20</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">#</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822004014/aclarion_ex9904.htm"><span style="font-size: 10pt">Nocimed, Inc. 2015 Stock Plan</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-8</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">05-26-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">99.4</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.21</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">#</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316822004014/aclarion_ex9905.htm"><span style="font-size: 10pt">Nocimed, Inc. 2015 Stock Plan &#8211; Form of Option Grant Notice and Stock Option Agreement</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-8</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">05-26-2022</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">99.5</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.22</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316823001027/aclarion_ex1001.htm"><span style="font-size: 10pt">Securities Purchase Agreement dated February 16, 2023 between Aclarion, Inc. and Jeffrey Thramann</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">02-17-2023</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.23</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316823003484/aclarion_ex1001.htm"><span style="font-size: 10pt">Form of Securities Purchase Agreement</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">05-17-2023</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.24</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316823003484/aclarion_ex1002.htm"><span style="font-size: 10pt">Form of Unsecured Non-Convertible Note</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">05-17-2023</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.2</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.25</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316823003484/aclarion_ex1003.htm"><span style="font-size: 10pt">Form of Common Stock Warrant</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">05-17-2023</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.3</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.26</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316823003484/aclarion_ex1004.htm"><span style="font-size: 10pt">Form of Registration Rights Agreement</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">05-17-2023</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.4</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.27</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316823005758/acon_ex1001.htm"><span style="font-size: 10pt">Waiver related to Unsecured Non-Convertible Notes</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">08-14-2023</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.28</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316823007017/aclarion_ex1001.htm"><span style="font-size: 10pt">White Lion Purchase Agreement</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">10-10-2023</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.29</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316823007017/aclarion_ex1002.htm"><span style="font-size: 10pt">White Lion Registration Rights Agreement</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">10-10-2023</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.2</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.30</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316824000730/aclarion_ex1031.htm"><span style="font-size: 10pt">February 2024 Form of Lock-Up Agreement</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">02-06-2024</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.31</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.31</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1635077/000168316824000730/aclarion_ex1032.htm"><span style="font-size: 10pt">February 2024 Form of Securities Purchase Agreement</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">S-1/A</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">02-06-2024</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.32</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.32</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316823008420/acon_ex1001.htm"><span style="font-size: 10pt">Form of Securities Purchase Agreement dated November 21, 2023</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">11-22-2023</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.33</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316823008420/acon_ex1002.htm"><span style="font-size: 10pt">Form of Unsecured Non-Convertible Note dated November 21, 2023</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">11-22-2023</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.2</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.34</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316823008420/acon_ex1003.htm"><span style="font-size: 10pt">Form of Common Stock Warrant dated November 21, 2023</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">11-22-2023</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.3</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.35</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316823008420/acon_ex1004.htm"><span style="font-size: 10pt">Form of Registration Rights Agreement dated November 21, 2023</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">11-22-2023</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.4</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.36</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316824000377/acon_ex1001.htm"><span style="font-size: 10pt">Form
    of January 2024 Exchange Agreement</span></a></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">8-K</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">01-23-2024</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top">10.37</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316824004374/aclarion_ex0401.htm">Form of Subscription Agreement</a></td>
    <td>&#160;</td>
    <td style="vertical-align: top">1-A/A</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">06-20-2024</td>
    <td>&#160;</td>
    <td style="vertical-align: top">4.1</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top">10.38</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316824005844/acon_ex1001.htm">Form of Exchange Agreement dated August 14, 2024</a></td>
    <td>&#160;</td>
    <td style="vertical-align: top">8-K</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">08-16-2024</td>
    <td>&#160;</td>
    <td style="vertical-align: top">10.1</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top">10.39</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316824006107/acon_ex1002.htm">Form of Warrant Purchase Agreement dated August 14, 2024</a></td>
    <td>&#160;</td>
    <td style="vertical-align: top">8-K</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">08-29-2024</td>
    <td>&#160;</td>
    <td style="vertical-align: top">10.2</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top">10.40</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316824006791/acon_ex1001.htm">Form of Securities Purchase Agreement dated September 30, 2024</a></td>
    <td>&#160;</td>
    <td style="vertical-align: top">8-K</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">10-01-2024</td>
    <td>&#160;</td>
    <td style="vertical-align: top">10.1</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top">10.41</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316824006791/acon_ex1002.htm">Form of Common Stock Warrant dated September 30, 2024</a></td>
    <td>&#160;</td>
    <td style="vertical-align: top">8-K</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">10-01-2024</td>
    <td>&#160;</td>
    <td style="vertical-align: top">10.2</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top">10.42</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316824006791/acon_ex1002.htm">Form of Registration Rights Agreement dated September 30, 2024</a></td>
    <td>&#160;</td>
    <td style="vertical-align: top">8-K</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">10-01-2024</td>
    <td>&#160;</td>
    <td style="vertical-align: top">10.3</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top">10.43</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316824006791/acon_ex1003.htm">Amendment dated as of November 27, 2024 to Common Stock Purchase Agreement, dated as of October 9, 2023, by and between White Lion Capital, LLC and Aclarion, Inc.</a></td>
    <td>&#160;</td>
    <td style="vertical-align: top">8-K</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">11-27-2024</td>
    <td>&#160;</td>
    <td style="vertical-align: top">10.1</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt;">23.1</span></td>
    <td style="vertical-align: top">***</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316824008624/aclarion_ex2301.htm">Consent
    of Haynie &amp; Company</a></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top">S-1</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">12-11-2024</td>
    <td>&#160;</td>
    <td style="vertical-align: top">23.1</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt;">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt;">23.2</span></td>
    <td>***</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316824008624/aclarion_ex2302.htm">Consent
    of CohnReznick LLP, Independent Registered Public Accounting Firm</a></span></td>
    <td>&#160;</td>
    <td>S-1</td>
    <td>&#160;</td>
    <td style="text-align: center">12-11-2024</td>
    <td>&#160;</td>
    <td>23.2</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt;">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt;">23.3</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt;">Consent of Carroll Legal
    LLC (included in <a href="aclarion_ex0501.htm">Exhibit 5.1</a>)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt;">X</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt;">24.1</span></td>
    <td>***</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316824008624/aclarion_s1.htm">Power
    of Attorney</a> (Included on Signature Page) </span></td>
    <td>&#160;</td>
    <td>S-1</td>
    <td>&#160;</td>
    <td style="text-align: center">12-11-2024</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt;">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-size: 10pt;">107</span></td>
    <td>***</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/1635077/000168316824008624/aclarion_ex107.htm">Filing
    Fees</a></span></td>
    <td>&#160;</td>
    <td>S-1</td>
    <td>&#160;</td>
    <td style="text-align: center">12-11-2024</td>
    <td>&#160;</td>
    <td>107</td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt;">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">____________________________</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">To be filed by amendment to this Registration Statement.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 4%"><span style="font-size: 10pt">**</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Certain information contained in this Exhibit has been redacted and appears as &#8220;XXXXX&#8221; as the disclosure of same would be a disadvantage to the Registrant in the marketplace</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">***</span></td>
    <td><span style="font-size: 10pt">Previously filed.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">#</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Indicates management contract or compensatory plan.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>(b) Financial statement schedules.</b>&#160;Schedules
not listed above have been omitted because the information required to be set forth therein is not applicable or is shown in the Financial
Statements or notes thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 209 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 9%; text-align: justify"><span style="font-size: 10pt"><b>Item 17.</b></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><b>Undertakings.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 5%; text-align: justify"><span style="font-size: 10pt">(a)</span></td>
    <td style="width: 95%; text-align: justify"><span style="font-size: 10pt">The undersigned registrant hereby undertakes:</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; text-align: justify"><span style="font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; text-align: justify">&#160;</td>
    <td style="white-space: nowrap; text-align: justify"><span style="font-size: 10pt">i.</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-size: 10pt">To include any prospectus required by Section&#160;10(a)(3)&#160;of the Securities Act of 1933;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; text-align: justify">&#160;</td>
    <td style="white-space: nowrap; text-align: justify"><span style="font-size: 10pt">ii.</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-size: 10pt">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule&#160;424(b)&#160;if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; text-align: justify">&#160;</td>
    <td style="white-space: nowrap; text-align: justify"><span style="font-size: 10pt">iii.&#160;</span></td>
    <td colspan="2" style="text-align: justify"><span style="font-size: 10pt">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; text-align: justify">&#160;</td>
    <td colspan="2" style="white-space: nowrap">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; text-align: justify"><span style="font-size: 10pt">(2)</span></td>
    <td colspan="3" style="text-align: justify"><span style="font-size: 10pt">That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</span></td></tr>
  <tr>
    <td style="width: 5%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 88%">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 5%; text-align: justify"><span style="font-size: 10pt">(3)</span></td>
    <td style="width: 95%; text-align: justify"><span style="font-size: 10pt">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; text-align: justify"><span style="font-size: 10pt">(4)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">That for the purpose of determining any liability under the Securities Act of 1933 in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 5%; text-align: justify">&#160;</td>
    <td style="white-space: nowrap; width: 5%; text-align: justify"><span style="font-size: 10pt">i.</span></td>
    <td style="width: 90%; text-align: justify"><span style="font-size: 10pt">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule&#160;424;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; text-align: justify">&#160;</td>
    <td style="white-space: nowrap; text-align: justify"><span style="font-size: 10pt">ii.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</span></td></tr>

<tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 5%; text-align: justify">&#160;</td>
    <td style="white-space: nowrap; width: 5%; text-align: justify"><span style="font-size: 10pt">iii.</span></td>
    <td style="width: 90%; text-align: justify"><span style="font-size: 10pt">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; text-align: justify">&#160;</td>
    <td style="white-space: nowrap; text-align: justify"><span style="font-size: 10pt">iv.</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 5%; text-align: justify"><span style="font-size: 10pt">(5)</span></td>
    <td style="width: 95%; text-align: justify"><span style="font-size: 10pt">That for the purpose of determining liability under the Securities Act of 1933 to any purchaser, if the registrant is subject to Rule&#160;430C, each prospectus filed pursuant to Rule&#160;424(b)&#160;as part of a registration statement relating to an offering, other than registration statements relying on Rule&#160;430B or other than prospectuses filed in reliance on Rule&#160;430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; text-align: justify"><span style="font-size: 10pt">(b)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 210 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 5%; text-align: justify"><span style="font-size: 10pt">(c)</span></td>
    <td style="width: 95%; text-align: justify"><span style="font-size: 10pt">The undersigned registrant hereby undertakes that:</span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; text-align: justify"><span style="font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule&#160;430A and contained in a form of prospectus filed by the registrant pursuant to Rule&#160;424(b)(1)&#160;or (4)&#160;or 497(h)&#160;under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; width: 5%; text-align: justify"><span style="font-size: 10pt">(2)</span></td>
    <td style="width: 95%; text-align: justify"><span style="font-size: 10pt">For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"></p>

<!-- Field: Page; Sequence: 211 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Pursuant to the requirements
of the Securities Act of 1933, as amended, the registrant has duly caused this Registration Statement on Form S-1 to be signed on its
behalf by the undersigned, thereunto duly authorized, in the city of Broomfield, in the State of Colorado, on this 26th day of December,
2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3"><span style="font-size: 10pt"><b>ACLARION, INC.</b></span></td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr>
    <td style="width: 51%">&#160;</td>
    <td style="vertical-align: top; width: 5%"><span style="font-size: 10pt">By:</span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 43%"><span style="font-size: 10pt">/s/ John Lorbiecki</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">John Lorbiecki</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chief Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Pursuant to the requirements
of the Securities Act of 1933, as amended, this Registration Statement on Form S-1 has been signed by the following persons in the capacities
and on the dates indicated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 28%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Signature</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 45%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 25%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Brent Ness</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 26, 2024</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brent Ness</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Director</span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ John Lorbiecki</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 26, 2024</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John Lorbiecki</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial and Accounting Officer)</span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Chairman and Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 26, 2024</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey Thramann</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 26, 2024</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Neal</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 26, 2024</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">William Wesemann</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 26, 2024</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amanda Williams</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 26, 2024</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen Deitsch</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 26, 2024</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott Breidbart</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">* <span style="text-decoration: underline">/s/ John Lorbiecki&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">John Lorbiecki</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attorney-in-Fact</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 212; Options: NewSection Last; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>



<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
</body>
</html>
